Farid Juya

3PUBLICATIONS
6CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 28, 2026
Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study.

Farid Juya, Kristin Klemmetsby Solli, Ann-Christin Sannes

|Apr 29, 2025
Pain intensity in patients using extended-release naltrexone or opioid agonists and its effect on extended-release naltrexone treatment outcomes.

Farid Juya, Kristin K Solli, Line Holtan

|Feb 26, 2025
Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study.

Farid Juya, Ann Christin Sannes, Kristin Klemmetsby Solli

Pageof 1

Frequent Collaborators

3 joint publications

Kristin Klemmetsby Solli

2 joint publications

Ann-Christin Sannes

2 joint publications

Bente Weimand

2 joint publications

Johannes Gjestad